Replimune (REPL) Change in Cash (2017 - 2026)
Replimune (REPL) posted Change in Cash of $86.1 million for Q1 2026, up 316.77% sequentially from $20.7 million in Q4 2025, and up 240.82% YoY from $25.3 million in Q1 2025.
Replimune (REPL) Change in Cash (2017 - 2026) Analysis & Trends
Replimune has reported Change in Cash for 10 years, with the latest figure at $86.1 million in Q1 2026.
- Quarterly Change in Cash rose 240.82% year-over-year to $86.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $97.9 million (up 167.03% YoY) and the FY2026 annual result came in at $97.9 million, up 167.03% from the prior year.
- Change in Cash improved to $86.1 million in Q1 2026 per REPL's latest filing, from $20.7 million in the prior quarter.
- Over five years, Change in Cash peaked at $117.7 million in Q4 2022 and troughed at -$61.1 million in Q1 2025.
- A 5-year average of $4.5 million and a median of -$13.7 million in 2025 frame the typical range for Change in Cash.
- The sharpest annual moves came in 2022 and 2023: Change in Cash surged 525.14% in 2022, then sank 736.95% in 2023.
- Over 5 years, Change in Cash stood at $117.7 million in 2022, then slumped by 81.59% to $21.7 million in 2023, then jumped by 171.02% to $58.7 million in 2024, then sank by 64.85% to $20.7 million in 2025, then jumped by 316.77% to $86.1 million in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered $86.1 million, $20.7 million, and $4.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 427.25 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.97 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.94 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Replimune | 1.24 Bn | 1.24 Bn | - | 86.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 86.07 Mn |
| Dec 31, 2025 | 20.65 Mn |
| Sep 30, 2025 | 4.92 Mn |
| Jun 30, 2025 | -13.74 Mn |
| Mar 31, 2025 | -61.12 Mn |
| Dec 31, 2024 | 58.75 Mn |
| Sep 30, 2024 | -38.16 Mn |
| Jun 30, 2024 | 77.20 Mn |
| Mar 31, 2024 | -23.15 Mn |
| Dec 31, 2023 | 21.68 Mn |
| Sep 30, 2023 | -30.49 Mn |
| Jun 30, 2023 | -40.11 Mn |
| Mar 31, 2023 | -60.08 Mn |
| Dec 31, 2022 | 117.74 Mn |
| Sep 30, 2022 | -23.32 Mn |
| Jun 30, 2022 | 6.30 Mn |
| Mar 31, 2022 | -26.33 Mn |
| Dec 31, 2021 | -27.69 Mn |
| Sep 30, 2021 | -32.56 Mn |
| Jun 30, 2021 | 10.01 Mn |